EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Tyrosinase Inhibitory Activity of Novel Benzimidazole/Thiazolidin‐4‐one Hybrid Derivatives

Leen Mohammad Amin Farhan Khraisat, Suna Sabuncuoğlu, Gözde Girgin iD, Oya Unsal Tan

Chemistry & Biodiversity · 2024

DOI: 10.1002/cbdv.202301489 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Leen Mohammad Amin Farhan Khraisat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, 06100, Ankara, Turkey. Hauptthemen laut MEDLINE: Agaricales, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, novel 3‐(phenylamino)thiazolidin‐4‐one 2 a – d and 3‐(phenyl)thiazolidin‐4‐one 3 a – g derivatives which are having benzimidazole moiety were synthesized and their tyrosinase inhibitory activity were investigated. The structures of the target compounds were elucidated using 1 H/ 13 C−NMR, IR and MS. The structure of 2 b was also characterized using HSQC NMR technique. Among the target compounds, 3 b – g demonstrated stronger tyrosinase inhibitory activity (IC 50 values for 3 b – g ranged from 80.93 to 119.20 μM), compared to the positive control kojic acid (IC 50 : 125.08 μM). With IC 50 value of 80.93 μM, 5‐(2‐(4‐(1 H ‐benzimidazol‐1‐yl)phenyl)‐4‐oxothiazolidin‐3‐yl)‐2‐methylbenzenesulfonamide 3 g was found to be the most active derivative of the series. Molecular docking studies were conducted to elucidate the binding interactions between compounds and tyrosinase. The MTT assay studies used to determine the cytotoxicity of 3 b – g showed that 3 c , 3 d , 3 f and 3 g were not cytotoxic in the range of 0–200 μM. Considering its tyrosinase inhibitory activity and cytotoxic effect, 3 g exhibits promising potential for further research and development as a novel tyrosinase inhibitor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgaricalesAntineoplastic AgentsStructure-Activity RelationshipMolecular StructureMonophenol MonooxygenaseMolecular Docking SimulationEnzyme InhibitorsDose-Response Relationship, DrugBenzimidazoles

Stichwörter der Autor:innen

BenzimidazoleCytotoxicityHSQCThiazolidin-4-oneTyrosinase inhibitory activity

Substanzen

Monophenol MonooxygenaseEnzyme InhibitorsAntineoplastic AgentsBenzimidazoles

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, 06100, Ankara, Turkey.
  • Department of Toxicology, Faculty of Pharmacy, Hacettepe University, 06100, Ankara, Turkey.

ORCID-Profile: Gözde Girgin

Zitieren

APA

Khraisat, L. M. A. F., Sabuncuoğlu, S., Girgin, G., & Unsal Tan, O. (2024). Synthesis and Tyrosinase Inhibitory Activity of Novel Benzimidazole/Thiazolidin‐4‐one Hybrid Derivatives. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202301489

Vancouver

Khraisat LMAF, Sabuncuoğlu S, Girgin G, Unsal Tan O. Synthesis and Tyrosinase Inhibitory Activity of Novel Benzimidazole/Thiazolidin‐4‐one Hybrid Derivatives. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202301489

BibTeX
@article{Khraisat2024,
  author = {Khraisat, Leen Mohammad Amin Farhan and Sabuncuoğlu, Suna and Girgin, Gözde and Unsal Tan, Oya},
  title = {Synthesis and Tyrosinase Inhibitory Activity of Novel Benzimidazole/Thiazolidin‐4‐one Hybrid Derivatives},
  journal = {Chemistry & Biodiversity},
  year = {2024},
  doi = {10.1002/cbdv.202301489}
}
Kostenlos starten →